MR imaging of the prostate.

[1]  Baris Turkbey,et al.  Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.

[2]  M. Roethke,et al.  Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla , 2014, European Radiology.

[3]  A. Rosenkrantz,et al.  3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. , 2013, Urologic oncology.

[4]  J. Babb,et al.  Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. , 2013, Radiology.

[5]  Oguz Akin,et al.  Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness. , 2013, Radiology.

[6]  J. Babb,et al.  Diffusion‐weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection , 2013, Journal of magnetic resonance imaging : JMRI.

[7]  J. Bomers,et al.  MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. , 2013, Radiology.

[8]  Chaya S Moskowitz,et al.  Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? , 2013, Radiology.

[9]  Xavier Leroy,et al.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.

[10]  H. Thoeny,et al.  Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site , 2013, BJU international.

[11]  J. Babb,et al.  Prostate cancer: Utility of diffusion‐weighted imaging as a marker of side‐specific risk of extracapsular extension , 2013, Journal of magnetic resonance imaging : JMRI.

[12]  Makoto Obara,et al.  Ultra‐high b‐value diffusion‐weighted MRI for the detection of prostate cancer with 3‐T MRI , 2013, Journal of magnetic resonance imaging : JMRI.

[13]  Baris Turkbey,et al.  Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? , 2013, Radiology.

[14]  M. Giger,et al.  Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. , 2013, Radiology.

[15]  Aytekin Oto,et al.  Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. , 2013, Radiology.

[16]  Aytekin Oto,et al.  MR imaging-guided focal laser ablation for prostate cancer: phase I trial. , 2013, Radiology.

[17]  Karin Haustermans,et al.  Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology , 2013, Journal of magnetic resonance imaging : JMRI.

[18]  T. Ishimori,et al.  Targeted Biopsy Based on ADC Map in the Detection and Localization of Prostate Cancer: A Feasibility Study , 2013, Journal of magnetic resonance imaging : JMRI.

[19]  C. Catalano,et al.  Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging , 2013, European Radiology.

[20]  G. Merrick,et al.  ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. , 2013, Journal of the American College of Radiology : JACR.

[21]  C. Pelizzari,et al.  Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. , 2013, International journal of radiation oncology, biology, physics.

[22]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[23]  Thomas Hambrock,et al.  Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.

[24]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[25]  Baris Turkbey,et al.  Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla , 2012, BJU international.

[26]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[27]  A. Costello,et al.  Re‐evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer , 2012, BJU international.

[28]  H. Hricak,et al.  The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience. , 2012, AJR. American journal of roentgenology.

[29]  Jurgen J Fütterer,et al.  MRI-guided interventions for the treatment of prostate cancer. , 2012, AJR. American journal of roentgenology.

[30]  Baris Turkbey,et al.  Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. , 2012, AJR. American journal of roentgenology.

[31]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[32]  T. Scheenen,et al.  Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. , 2012, Radiology.

[33]  Lorenzo Bonomo,et al.  T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations. , 2012, European journal of radiology.

[34]  H. Hricak,et al.  Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. , 2012, The Journal of urology.

[35]  W. I. Tseng,et al.  Washout gradient in dynamic contrast‐enhanced MRI is associated with tumor aggressiveness of prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[36]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[37]  Takeshi Yoshikawa,et al.  Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.

[38]  Baris Turkbey,et al.  Multiparametric MRI and prostate cancer diagnosis and risk stratification , 2012, Current opinion in urology.

[39]  B. Bloch,et al.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI , 2012, European Radiology.

[40]  S. Mendrinos,et al.  Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. , 2012, The Journal of urology.

[41]  H. Hricak,et al.  Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. , 2012, Radiology.

[42]  Sadhna Verma,et al.  Imaging-guided prostate biopsy: conventional and emerging techniques. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[43]  Philippe Puech,et al.  MRI and surveillance , 2012, Current opinion in urology.

[44]  F. Beuvon,et al.  Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? , 2012, European journal of radiology.

[45]  Beom Jin Park,et al.  Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI , 2012, European Radiology.

[46]  H. Hricak,et al.  Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. , 2012, Radiology.

[47]  Karin Haustermans,et al.  Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology. , 2012, European journal of radiology.

[48]  Mana Ishibashi,et al.  Detection and Localization of Prostate Cancer With the Targeted Biopsy Strategy Based on ADC Map: A Prospective Large-Scale Cohort Study , 2012, Journal of magnetic resonance imaging : JMRI.

[49]  Oguz Akin,et al.  MR imaging of treated prostate cancer. , 2012, Radiology.

[50]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[51]  D. Schilling,et al.  MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy , 2012, World Journal of Urology.

[52]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[53]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[54]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[55]  J. K. Kim,et al.  Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. , 2011, AJR. American journal of roentgenology.

[56]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[57]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[58]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[59]  T. Sone,et al.  Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.

[60]  T. Sone,et al.  Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. , 2011, AJR. American journal of roentgenology.

[61]  Matthew R Cooperberg,et al.  Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[63]  Dan Stoianovici,et al.  Advancements in MR imaging of the prostate: from diagnosis to interventions. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[64]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[65]  François Cornud,et al.  Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.

[66]  A. Partin,et al.  A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. , 2011, The Journal of urology.

[67]  Aaron Fenster,et al.  Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.

[68]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[69]  Ralph Strecker,et al.  Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.

[70]  C. Parker,et al.  Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components. , 2011, AJR. American journal of roentgenology.

[71]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[72]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[73]  A. Verbaeys,et al.  Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. , 2011, European journal of radiology.

[74]  P. Choyke,et al.  D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. , 2010, The Journal of urology.

[75]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[76]  M. Özmen,et al.  The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings. , 2011, Diagnostic and interventional radiology.

[77]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[78]  Pär Stattin,et al.  Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study , 2010, Journal of the National Cancer Institute.

[79]  P. Carroll,et al.  Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. , 2010, Radiology.

[80]  J. Babb,et al.  Prostate cancer vs. post‐biopsy hemorrhage: Diagnosis with T2‐ and diffusion‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[81]  T. Scheenen,et al.  Prostate MRI and 3D MR spectroscopy: how we do it. , 2010, AJR. American journal of roentgenology.

[82]  A. Evans,et al.  ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging , 2010, BJU international.

[83]  A. Evans,et al.  Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.

[84]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[85]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[86]  Peter C Albertsen,et al.  The unintended burden of increased prostate cancer detection associated with prostate cancer screening and diagnosis. , 2010, Urology.

[87]  Bachir Taouli,et al.  Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. , 2010, AJR. American journal of roentgenology.

[88]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[89]  Y. Yamashita,et al.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.

[90]  Alexandre Mamedov,et al.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  D. Dearnaley,et al.  A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.

[92]  Peter H Gann,et al.  Prostate specific antigen best practice statement: 2009 update. , 2009, The Journal of urology.

[93]  J. Epstein,et al.  Letters to the Editor/Errata Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails , 2010 .

[94]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[95]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[96]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[97]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[98]  Neil Fleshner,et al.  The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate‐specific antigen levels , 2009, BJU international.

[99]  P. Gabriele,et al.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging , 2009, European Radiology.

[100]  Olivier Rouvière,et al.  Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy , 2009, European Radiology.

[101]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[102]  Katarzyna J Macura,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Evaluation of the Prostate , 2008, Topics in magnetic resonance imaging : TMRI.

[103]  Deanna L Langer,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[104]  Derya Yakar,et al.  Magnetic Resonance-Guided Biopsy of the Prostate: Feasibility, Technique, and Clinical Applications , 2008, Topics in magnetic resonance imaging : TMRI.

[105]  Thomas Hambrock,et al.  Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative radiology.

[106]  Katsuyoshi Ito,et al.  Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.

[107]  Roberto Passariello,et al.  Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. , 2008, European urology.

[108]  Katarzyna J Macura,et al.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.

[109]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[110]  N M deSouza,et al.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.

[111]  Michael Phillips,et al.  Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. , 2008, The Journal of urology.

[112]  Masoom A Haider,et al.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[113]  Hiroshi Honda,et al.  Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.

[114]  H. Hricak,et al.  Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.

[115]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.

[116]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[117]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[118]  V. Pansadoro,et al.  Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone , 2007, Abdominal Imaging.

[119]  A. Hemal,et al.  Transrectal ultrasound‐guided biopsy of prostate voxels identified as suspicious of malignancy on three‐dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/ml , 2007, NMR in biomedicine.

[120]  Anthony D'Amico,et al.  Prostate cancer. Clinical practice guidelines in oncology. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[121]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[122]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[123]  Heinz-Peter Schlemmer,et al.  MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.

[124]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[125]  Michael McCormack,et al.  Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. , 2006, European urology.

[126]  Yuri Kitamura,et al.  Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.

[127]  H. Hricak,et al.  Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. , 2006, Radiology.

[128]  U. Patel,et al.  Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. , 2006, Clinical radiology.

[129]  B. Kiefer,et al.  Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device , 2006, European Radiology.

[130]  J Alfred Witjes,et al.  Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.

[131]  Seong Ho Park,et al.  Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization , 2005, Journal of magnetic resonance imaging : JMRI.

[132]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[133]  D. Beyersdorff,et al.  MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. , 2005, Radiology.

[134]  P. Carroll,et al.  Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.

[135]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[136]  Jun Nakashima,et al.  Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. , 2004, Urology.

[137]  Michael W Kattan,et al.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.

[138]  J. Crowley,et al.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.

[139]  Olivier Rouvière,et al.  Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. , 2004, Urology.

[140]  S. Zangos,et al.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results , 2004, European Radiology.

[141]  M. Terris,et al.  Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. , 2003, Urology.

[142]  Steven Piantadosi,et al.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. , 2003, The Journal of urology.

[143]  Koji Okihara,et al.  Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. , 2002, Urology.

[144]  Bernd Hamm,et al.  Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.

[145]  O. Hélénon,et al.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, Radiology.

[146]  William J Catalona,et al.  Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.

[147]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[148]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[149]  G. Durkan,et al.  Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. , 2002, BJU international.

[150]  A W Partin,et al.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.

[151]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[152]  T Okada,et al.  Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. , 2001, Urology.

[153]  T. Stamey,et al.  An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.

[154]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[155]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[156]  S. Piantadosi,et al.  Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.

[157]  W. Fair,et al.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.

[158]  D. Bostwick.  Staging prostate cancer--1997: current methods and limitations. , 1997, European urology.

[159]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[160]  D. Mitchell,et al.  Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. , 1994, Radiology.

[161]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[162]  David J. Grignon,et al.  The Prostatic Capsule: Does It Exist? Its Importance in the Staging and Treatment of Prostatic Carcinoma , 1989, The American journal of surgical pathology.

[163]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.